Header Logo

Connection

Kate Lapane to Prenatal Exposure Delayed Effects

This is a "connection" page, showing publications Kate Lapane has written about Prenatal Exposure Delayed Effects.
  1. Wood ME, Frazier JA, Nordeng HM, Lapane KL. Longitudinal changes in neurodevelopmental outcomes between 18 and 36?months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study. BMJ Open. 2016 09 13; 6(9):e011971.
    View in: PubMed
    Score: 0.601
  2. Wood ME, Frazier JA, Nordeng HM, Lapane KL. Prenatal triptan exposure and parent-reported early childhood neurodevelopmental outcomes: an application of propensity score calibration to adjust for unmeasured confounding by migraine severity. Pharmacoepidemiol Drug Saf. 2016 05; 25(5):493-502.
    View in: PubMed
    Score: 0.567
  3. Wood ME, Lapane KL, van Gelder MMHJ, Rai D, Nordeng HME. Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control. Pharmacoepidemiol Drug Saf. 2018 02; 27(2):140-147.
    View in: PubMed
    Score: 0.162
  4. Wood ME, Lapane K, Frazier JA, Ystrom E, Mick EO, Nordeng H. Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study. Paediatr Perinat Epidemiol. 2016 Mar; 30(2):190-200.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.